Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.8100
0.00 (0.00%)
At close: Apr 29, 2025, 4:00 PM
0.8000
-0.0100 (-1.23%)
Pre-market: Apr 30, 2025, 8:43 AM EDT
CNTB Revenue
In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M. Connect Biopharma Holdings had revenue of $1.92M in the half year ending December 31, 2024.
Revenue (ttm)
$26.03M
Revenue Growth
n/a
P/S Ratio
1.72
Revenue / Employee
$419,887
Employees
62
Market Cap
44.83M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
CNTB News
- 5 days ago - Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - Connect Biopharma to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 7 months ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire
- 7 months ago - CNTB Stock Dips Amid Biotech Sector Volatility - GuruFocus